LensHooke X1 Pro Semen Quality Analyzer, LensHooke X1 Semen Quality Analyzer

The LensHooke X1 series Semen Quality Analyzers are optical in-vitro diagnostic devices employing artificial intelligence-enhanced image analysis to provide quantitative measurements of key semen parameters including concentration, motility, morphology, and pH for male fertility assessment. These analyzers, available for both home (X1) and professional (X1 PRO) use, offer an automated method for evaluating sperm quality by processing microscopic images of semen samples obtained via a disposable test cassette.

The LensHooke X1 Semen Quality Analyzer and its professional counterpart, the LensHooke X1 PRO, are optical in-vitro diagnostic systems designed for human semen analysis to aid in the evaluation of male fertility. The X1 model is intended for over-the-counter (OTC) home use by individuals, allowing for self-testing, while the X1 PRO model is for prescription use in healthcare professional settings. Both systems utilize a disposable LensHooke Semen Test Cassette and integrate optical design with artificial intelligence-driven image analysis to provide quantitative measurements. Core parameters assessed by both include sperm concentration (10^6 per ml), total motility (Progressive + Non-Progressive, %), sperm morphology (normal forms, %), and semen pH value. The X1 PRO version offers a more detailed motility analysis by distinguishing between progressive motility (%) and non-progressive motility (%). The underlying science involves capturing images via integrated cameras and employing specific image processing methods. Sperm concentration is determined by analyzing sperm unit density. Sperm motility is calculated by tracing sperm trajectories, while morphology is assessed by comparing sperm head and tail percentages. Semen pH is measured by capturing a chromatographic image of pH paper within the cassette and analyzing its saturation and brightness. Non-clinical performance validation demonstrated high repeatability and reproducibility (CV <10%), defined limits of detection (LoD: 1.8 x10^6/mL sperm), and linearity across relevant ranges for sperm concentration (2-350 x10^6/mL) and pH (5.8-8.2). The system also showed resilience to interferents and stable operation under varied environmental conditions (15-38°C, 50-90% RH). Clinical studies, including a lay-user performance study with 100 participants using the OTC X1 model, confirmed user accuracy and ease of use when compared to a reference laboratory method.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the artificial intelligence image processing algorithm differentiate between sperm head and tail percentages for morphology analysis, and what is its validated accuracy against manual microscopic assessment by trained andrologists?; What specific endogenous and exogenous substances were tested as potential interferents, and at what concentrations, particularly those commonly found in semen or due to lifestyle factors?; Could the device's analytical capabilities be adapted or validated for use in post-vasectomy semen analysis to confirm azoospermia, and what would be the expected limit of detection for that application?; What are the precise performance differences, particularly in terms of accuracy, precision, and inter-run variability for motility differentiation (progressive vs. non-progressive), between the over-the-counter (X1) and professional (X1 PRO) versions?; Beyond the currently reported parameters, does the system capture raw image data or other sub-metrics (e.g., sperm kinematic parameters beyond basic motility categories) that could be leveraged for future research into more nuanced aspects of sperm function or male fertility?